InsiderTrades

Form 4 for VKTX Viking Therapeutics, Inc.

Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-29 · accession 0000950170-24-088538 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-07-31 2024-07-29 VKTX ZANTE GREG CFO A - Grant $0.00 +28.3K 181.5K +18% $0
M 2024-07-31 2024-07-30 VKTX ZANTE GREG CFO S - Sale $57.15 -16.1K 187.1K -8% -$922.2K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.00001 per share 2024-07-29 A A 21,667 $0.00 203,188 D — — (F2) The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2024, 33.33% of which vested on July 29, 2024 upon the achievement of a non-financial performance goal.
2 Common Common Stock, par value $0.00001 per share 2024-07-29 A A 6,667 $0.00 181,521 D — — (F1) The reported securities were subject to a performance restricted stock unit award that was granted on January 4, 2021, 33.33% of which vested on July 29, 2024 upon the achievement of a non-financial performance goal.
3 Common Common Stock, par value $0.00001 per share 2024-07-30 S D 2,974 $57.71 187,552 D — — (F3) These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.46 to $58.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4 Common Common Stock, par value $0.00001 per share 2024-07-30 S D 12,662 $56.96 190,526 D — — (F3) These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.46 to $57.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
5 Common Common Stock, par value $0.00001 per share 2024-07-30 S D 500 $58.71 187,052 D — — (F3) These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock unit awards. (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.54 to $58.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.